glycopyrrolate has been researched along with Delusional Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Munoli, RN; Praharaj, SK; Sharma, PS | 1 |
| Andrade, C; Bambole, V; Bang, A; Shah, N; Sonavane, S | 1 |
2 other study(ies) available for glycopyrrolate and Delusional Disorder
| Article | Year |
|---|---|
Low-dose glycopyrrolate for clozapine-associated sialorrhea.
Topics: Adult; Antipsychotic Agents; Clozapine; Glycopyrrolate; Humans; Male; Muscarinic Antagonists; Schizophrenia, Paranoid; Sialorrhea; Treatment Outcome | 2014 |
Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness.
Topics: Adolescent; Anti-Dyskinesia Agents; Antipsychotic Agents; Atropine; Benzodiazepines; Blindness, Cortical; Electroconvulsive Therapy; Female; Glycopyrrolate; Haloperidol; Humans; Muscarinic Antagonists; Olanzapine; Panic; Schizophrenia, Paranoid; Treatment Outcome; Trihexyphenidyl | 2012 |